Related Experiment Video
Updated: Aug 7, 2026
12:24
Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy
Published on: September 29, 2016
Targeting signal transduction for disease therapy
1Department of Biological Chemistry, Alexander Silberman Institute of Life Sciences, Hebrew University of Jerusalem, Givat Ram, Israel. LEVITZKI@vms.huji.ac.il
Medical Oncology (Northwood, London, England)
|June 1, 1997
Summary
Targeting aberrant molecular signaling pathways offers new therapeutic strategies for cancers and proliferative disorders. This approach leverages advances in molecular understanding to develop novel disease management techniques.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Signaling
Background:
- Cancers and proliferative disorders are characterized by pathological alterations in molecular signaling pathways.
- Understanding these molecular machineries has advanced significantly since the early 1980s.
Purpose of the Study:
- To explore the therapeutic potential of targeting aberrant signaling pathways in proliferative diseases.
- To present evidence supporting the validity of this targeted therapeutic approach.
Main Methods:
- Investigated the molecular basis of cancers and proliferative disorders.
- Focused on identifying and characterizing aberrant signaling pathways involved in disease pathogenesis.
- Developed and evaluated strategies for targeting these specific pathways.
Main Results:
- Demonstrated pathological alterations in molecular signaling pathways are a key feature of these diseases.
- Provided evidence supporting the feasibility and efficacy of targeting aberrant pathways for therapeutic intervention.
Conclusions:
- Targeting aberrant signaling pathways represents a promising new therapeutic strategy for managing cancers and proliferative disorders.
- Advances in molecular understanding are crucial for developing effective, targeted disease management approaches.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...